CTLA4 and neoplasm: Dendritic cells express programmed death ligand 1 and the ligand for cytotoxic T-lymphocyte-associated protein 4, inducing to down-regulation of antigen processing and inhibition of the effector function of tumor-infiltrating lymphocytes [23].